Last edition
News about
TempraMed Expands to Turkey With Exclusive Distribution Deal for VIVI Products
TempraMed Technologies Ltd, a leader in smart temperature-controlled medical devices, has signed an exclusive distribution agreement with Dolfin Saglik Ürünleri, one of Turkey’s most established healthcare and medical device companies.
Philips Unveils World's First Helium-free 3.0T MRI Platform
Philips has introduced the world’s first helium-free 3.0T MRI platform, the BlueSeal Horizon, marking a significant technological milestone in medical imaging. The new system combines a fully sealed, helium-independent magnet with advanced AI tools to deliver faster workflows, improved sustainability, and enhanced clinical insights.
Syntegon Makes Spare Parts Sourcing Easier with Mysyntegon Webshop
Syntegon has introduced a new digital platform, the mySyntegon webshop, designed to simplify machine spare-parts sourcing and ordering through AI-driven image recognition.
TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen
Kytopen has strengthened its European footprint with a new partnership granting TQ Therapeutics on-site access to its non-viral Flowfect Tx cellular engineering platform. The collaboration will support integration of the technology into TQ’s CELLfinity platform.
FDA Approves Expanded Use of Eli Lilly's Jaypirca in Relapsed or Refractory CLL/SLL
Eli Lilly’s Jaypirca (pirtobrutinib) is the only medicine in CLL or SLL that has been prospectively studied in a randomised trial of patients previously treated with a covalent BTK inhibitor.
Cipla Partners with Stempeutics, Launches Stem Cell Therapy for Knee Osteoarthritis
Cipla has partnered with Stempeutics to launch Ciplostem, a single-dose stem cell therapy for knee osteoarthritis. The treatment uses 25 million expanded Bone Marrow–derived Mesenchymal Stem Cells (BM-MSCs) combined with hyaluronic acid to support joint repair and pain relief.
Nona Biosciences Taps Dr. Hongjiang Miao to Advance A3 Strategy and AI-Driven Drug Discovery
Dr. Hongjiang Miao will lead the Nona AI team to advance the company's A3 (Antibody engineering × AI × Automation) strategy and further transform Nona into an AI-driven drug discovery company.
Sun Pharma Announces Major INR 3,000 Crore Expansion in MP
Sun Pharmaceutical Industries’ wholly owned subsidiary, Sun Pharma Laboratories Ltd, has approved an investment of INR 3,000 crore to set up a new greenfield formulations manufacturing facility in Madhya Pradesh.
Citius Oncology Launches Lymphir, a Novel FDA-Approved Therapy for Relapsed or Refractory CTCL
According to Leonard Mazur, chairman and CEO of Citius Oncology and Citius Pharmaceuticals, the launch of Lymphir marks a major milestone for the company. He highlighted its median time to response of 1.4 months, noting that the therapy may provide rapid relief from the severe and debilitating itching associated with CTCL.
WHO Issues First Global Guideline on GLP-1 Therapies for Obesity
To tackle the growing global health challenge of obesity—which now affects more than one billion people worldwide—the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy